Synonyms: example I-147 [US20210094956A1]
Compound class:
Synthetic organic
Comment: The chemical structure for paltimatrectinib was revealed in WHO proposed INN list 126 (Jan 2022), in which it was described as a tyrosine kinase inhibitor and antineoplastic agent. It is one of the compounds claimed in Pyramid Biosciences' TRK inhibitor patent US20210094956A1 [1]. Paltimatrectinib may be Pyramid's clinical candidate pan-TRK inhibitor PBI-200, that is being evaluated in TRK fusion cancers, but as of Feb 2022 there has been no formal name-to-structure disclosure. An abstract from the 2019 AACR meeting in Atlanta (USA) describes PBI-200 [2].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]-3-[4-(trifluoromethyl)pyrazol-1-yl]pyrazolo[1,5-a]pyrimidine |
Synonyms |
example I-147 [US20210094956A1] |
Database Links | |
CAS Registry No. | 2353522-15-1 (source: WHO INN record) |
GtoPdb PubChem SID | 461663436 |
PubChem CID | 155753054 |
Search Google for chemical match using the InChIKey | FYPXPQSPRRZJCK-MRXNPFEDSA-N |
Search Google for chemicals with the same backbone | FYPXPQSPRRZJCK |
UniChem Compound Search for chemical match using the InChIKey | FYPXPQSPRRZJCK-MRXNPFEDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FYPXPQSPRRZJCK-MRXNPFEDSA-N |